Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Monday, October 26, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Venture Capital
Venture Capital
Venture Capital
Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease
Life Sciences Times
-
October 16, 2026
Venture Capital
Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments
Life Sciences Times
-
October 15, 2026
Venture Capital
Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies
Life Sciences Times
-
October 13, 2026
Venture Capital
Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy
Life Sciences Times
-
October 5, 2026
Venture Capital
ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies
Life Sciences Times
-
September 29, 2026
Venture Capital
Thermo Fisher Scientific Completes Acquisition of The Binding Site Group
Life Sciences Times
-
January 3, 2023
0
Venture Capital
Johnson & Johnson Completes Acquisition of Abiomed
Life Sciences Times
-
December 28, 2022
0
Venture Capital
Enveda Biosciences Closes $68-million Combined Series B Equity and Debt Financing
Life Sciences Times
-
December 21, 2022
0
Venture Capital
Parallel Bio Secures $4.3 Million Seed Round to Accelerate Drug Discovery through Human Immune System in a Dish
Life Sciences Times
-
December 20, 2022
0
Venture Capital
Ganymede Bio, the Cloud Provider Purpose-Built for the Life Sciences and Manufacturing Industries, Raises $12.75 Million in Series A Funding
Life Sciences Times
-
December 20, 2022
0
Venture Capital
Kite to Acquire Tmunity Therapeutics to Pursue Next Generation CAR T-Cell Therapy Advancements in Cancer
Life Sciences Times
-
December 20, 2022
0
Venture Capital
TailorMed Strengthens Nation’s Largest Network of Patients, Providers, Pharmacies, and Life Science Companies with Support from Ballad Ventures, Inception Health, and University Hospitals Ventures
Life Sciences Times
-
December 19, 2022
0
Venture Capital
Maxar Technologies To Be Acquired by Advent International for $6.4 Billion
Life Sciences Times
-
December 16, 2022
0
Venture Capital
Harrow Secures Capital to Close Recently Announced Acquisition
Life Sciences Times
-
December 16, 2022
0
Venture Capital
Vizabli, Inc. Completes $2.5M Seed Round Financing
Life Sciences Times
-
December 16, 2022
0
Venture Capital
Henry Schein Makes Investment to Form Strategic Partnership With Biotech Dental Group
Life Sciences Times
-
December 16, 2022
0
Venture Capital
Edison Partners invests $15 million in Schedule K-1 automation disruptor K1x, Inc.
Life Sciences Times
-
December 15, 2022
0
1
...
55
56
57
...
115
Page 56 of 115
Most Read
Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment
October 23, 2026
Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment
October 23, 2026
Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment
October 23, 2026
Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment
October 23, 2026